Aster Capital Management (Difc) LTD Cassava Sciences Inc Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Cassava Sciences Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 5 shares of SAVA stock, worth $13. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 17
70.59%
Holding current value
$13
Previous $500,000
97.6%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SAVA
# of Institutions
190Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$8.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$7.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.81 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$2.78 Million0.0% of portfolio
-
Ubs Group Ag931KShares$2.6 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $112M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...